Evaluating allogeneic transplant for TP53 mutated acute myeloid leukemia
The Medical News,
A new editorial was published in Oncotarget's Volume 15 on October 1, 2024, entitled, "Transplant or no transplant for TP53…
TP53 Mutated AML: To Transplant or Not?
Mirage News,
"In summary, this study reported improved survival when allo-HTC was performed in CR1 versus after later lines of therapy.…
TP53 mutated AML: Transplant or No Transplant
EurekAlert!,
“In summary, this study reported improved survival when allo-HTC was performed in CR1 versus after later lines of therapy.…
TP53 Mutated AML: Transplant or No Transplant
Oncotarget Press Releases,
In summary, this study reported improved survival when allo-HTC was performed in CR1 versus after later lines of therapy.